The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 4 , Pages 938-944 , April 2003

Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma

Read at the Twenty-eighth Annual Meeting of The Western Thoracic Surgical Association, Big Sky, Mont, June 19-22, 2002.

Received 10 July 2002 ,Revised 7 October 2002 ,Accepted 18 October 2002.

References 

  1. Gould MK, Maclean CC, Kuschner WG, et al.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions. JAMA. 2001;285:914–924
  2. McCain TW, Dunagan DP, Chin R, et al.  The usefulness of positron emission tomography in evaluating patients for pulmonary malignancies. Chest. 2000;118:1610–1615
  3. Gupta NC, Graeber GM, Bishop HA, et al.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small, intermediate and large lymph node lesions. Chest. 2000;117:773–778
  4. Pieterman RM, van Putten JWG, Meuzelaar JJ, et al.  Preoperative staging of non-small cell lung cancer with positron emission tomography. N Engl J Med. 2000;343:254–261
  5. Dietlein M, Weber K, Detlef M, et al.  Cost-effectiveness of FDG-PET for the management of potentially operable non-small lung cancer: priority for a PET-based strategy after nodal negative CT results. Eur J Nucl Med. 2000;27:1598–1609
  6. Roberts PF, Follette DM, von Haag D, et al.  Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg. 2000;70:1154–1160
  7. Hagge RJ, Wong TZ, Coleman RE, et al.  Positron emission tomography: brain tumors and lung cancer. Radiol Clin North Am. 2001;39:871–881
  8. Savelli G, Maffioli L, Maccauro M, et al.  Bone scintigraphy and the added value of SPECT in detecting skeletal lesions. Q J Nucl Med. 2001;45:27–37
  9. Strauss LG. Sensitivity and specificity of positron emission tomography for the diagnosis of lymph node metastases. Recent Results Cancer Res. 2000;157:12–19
  10. Boiselle PM. MR imaging of thoracic lymph nodes. A comparison of computed tomography and positron emission tomography. Magn Reson Imaging Clin North Am. 2000;8:33–41
  11. Al-Sugair A, Coleman RE. Applications of PET in lung cancer. Semin Nucl Med. 1998;28:303–319
  12. Boiselle PM, Patz EF, Vining DJ, et al.  Imaging of mediastinal lymph nodes: CT, MR, and FDG-PET. Radiographics. 1998;18:1061–1069
  13. Poncelet AJ, Lonneux M, Coche E, et al.  PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma. Eur J Cardio Thorac Surg. 2001;20:468–475
  14. Liewald F, Grobe S, Guhlman A, et al.  How useful is PET for lymph node staging in non-small cell lung cancer?. Thorac Cardiovasc Surg. 2000;48:93–96
  15. Beyer T, Townsend DW, Brun T, et al.  A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369–1379
  16. Akhurst T, Downey RJ, Ginsburg MS, et al.  An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg. 2002;73:259–266
  17. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710–1717
  18. Cerfolio, RJ, Ojha BC. The Role of FDG-PET scan in patients with mon-small cell lung cancer in the Southeastern United States. Ann Thorac Surg. In press.
  19. Vansteenkiste JF, Stroobants SG, DeLeyn PR, et al.  Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. Ann Oncol. 1998;9:1193–1198

 Address for reprints: Robert J. Cerfolio, MD, Associate Professor of Surgery, Division of Cardiothoracic Surgery, University of Alabama at Birmingham, 1900 University Blvd, THT 712, Birmingham, AL 35294 (E-mail: Robert.cerfolio@ccc.uab.edu).

☆☆ 0022-5223/2003 $30.00+0

PII: S0022-5223(03)00072-2

doi: 10.1067/mtc.2003.381

The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 4 , Pages 938-944 , April 2003